HCP Live March 30, 2024
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE

In this episode, hosts discuss GLP-1 RA use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and practical application of artificial intelligence into care.

In the third and final recap episode from the 17th annual International Conference on Advanced Technologies & Treatments for Diabetes, hosts of Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives Diana Isaacs, PharmD, and Natalie Bellini, DNP, take a deep dive into a series of topics from the meeting, including GLP-1 receptor agonist use and CGM technology, updates in once-weekly insulins, the concept of continuous ketone monitoring, and application of artificial intelligence into care.

For more on ATTD 2024, check out our other ATTD 2024 episodes on All Things Automated Insulin Delivery...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Digital Health, Patient / Consumer, Provider, Technology, Trends, Wearables
Related Articles:
Why doctors increasingly turn away from rural clinical practice
More than half of US adults could benefit from GLP-1 medications, researchers find
Concerns raised over Indiana hospital merger
Self-governance in the medical profession and medical malpractice
Unlocking The Genetic Code: AI Reveals New Insights Into Psychiatric Disorders

Share This Article